Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Pyrroline hydroxycarboxylic acid)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST001855 AN003006 The metabolomic resetting effect of FG4592 in AKI to CKD transition-day 21 (Part 1) Kidney Mouse Kidney disease Children's Hospital of Nanjing Medical University AUC
ST001610 AN002644 Control (DMSO 0.1%; v/v) and 10 µM DRB18 treated A549 lung cancer cells in vitro for 48 hours Lung Human Cancer Ohio University Normalized abundances
ST002467 AN004023 Nano-hijacked myeloid cells potentiate antitumor immunity and radiotherapy for glioblastoma Brain Mouse Cancer Northwestern University, Feinberg School of Medicine Normalized peak area
ST000164 AN000257 Metabolomic analysis of normal and diabetic mouse bone marrow under PBS or metformin treatment Bone marrow Mouse Diabetes New York University Peak area
ST000242 AN000377 Whole unconditioned medium (Defined culture media, M199),Whole M1 medium,Whole M2 medium Macrophages Human Mayo Clinic Peak area
ST002846 AN004664 Apolipoprotein E suppresses hyperlipidemia-driven hematopoiesis & inflammation by controlling mitochondrial metabolism Macrophages Mouse Hyperlipidemia Northwestern University Peak area
ST002876 AN004713 High Level Expression of NSD2 Creates a Metabolic Dependency in Multiple Myeloma B-cells Human Cancer University of Florida Peak area
ST003249 AN005322 Mitochondrial respiration impairment in microglia dampens response to demyelinating injury but is not sufficient to induce an aging phenotype Microglia Mouse Alzheimers disease Northwestern University Peak area
ST003262 AN005346 A Covalent Creatine Kinase Inhibitor Ablates Glioblastoma Migration and Sensitizes Tumors to Oxidative Stress. Brain Human Cancer Northwestern University, Feinberg School of Medicine Peak area
ST003024 AN004958 Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 1 Bacterial cells Pseudomonas aeruginosa Monash Institute of Pharmaceutical Sciences peak height
ST000421 AN000665 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
  logo